Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Bernstein bets on Indian healthcare, sees these three stocks as key beneficiaries
According to Bernstein, valuations across the Indian biopharma sector have re-rated significantly, with the Nifty Pharma index trading slightly above its 10-year average multiple of 30.5 times its one-year forward earnings. However, it noted that its preferred stocks continue to trade below their long-term average valuations.
Ipca Laboratories Ltd soars 0.79%, rises for fifth straight session
Ipca Laboratories Ltd is quoting at Rs 1654.8, up 0.79% on the day as on 12:44 IST on the NSE. The stock is up 20.85% in last one year as compared to a 7.43% spurt in NIFTY and a 11.54% spurt in the Nifty Pharma.
Here is the one sector bucking the trend in a weak market; Check out top gainers
Five among the top 10 gainers on the Nifty 500 index are Pharma stocks. They include Pfizer (Up 4.6%), Anthem Biosciences (Up 2.5%), Syngene (Up 2%), Aster DM Healthcare (Up 2%) and Wockhardt (Up 2%).
Ajanta Pharma Ltd gains for third straight session
Ajanta Pharma Ltd is quoting at Rs 2993.7, up 1.56% on the day as on 12:49 IST on the NSE. The stock is up 16.43% in last one year as compared to a 6.52% jump in NIFTY and a 12.16% jump in the Nifty Pharma index.
Abbott India Ltd drops for fifth straight session
Abbott India Ltd is quoting at Rs 26020, down 1.03% on the day as on 13:19 IST on the NSE. The stock jumped 5.41% in last one year as compared to a 5.65% slide in NIFTY and a 11.71% spurt in the Nifty Pharma index.
Sun Pharmaceutical Industries Ltd drops for fifth straight session
Sun Pharmaceutical Industries Ltd is quoting at Rs 1774.1, down 0.81% on the day as on 13:19 IST on the NSE. The stock jumped 5.41% in last one year as compared to a 5.65% slide in NIFTY and a 11.71% spurt in the Nifty Pharma index.
Ipca Laboratories Ltd gains for third straight session
Ipca Laboratories Ltd is quoting at Rs 1598.7, up 2.83% on the day as on 12:49 IST on the NSE. The stock is up 15.35% in last one year as compared to a 5.46% jump in NIFTY and a 11.8% jump in the Nifty Pharma index.
After a dull Q4, Glenmark Pharma needs a booster shot to grow
Investors are shifting their focus to core operational execution as the drugmaker looks past one-off licensing gains to drive its FY27 growth.
Top Gainers & Losers on June 2: Newgen Software Tech, Concord Biotech, TCS, HFCL, NMDC among top gainers
On June 2, Indian stocks rebounded with benchmarks up over 0.5%, driven by technology shares. The Nifty 50 and Sensex closed at 23,506 and 74,692, respectively. However, India fell to seventh in global market capitalisation due to overseas selling and weak earnings growth.
Piramal Pharma Ltd drops for fifth straight session
Piramal Pharma Ltd is quoting at Rs 165.7, down 3.04% on the day as on 13:19 IST on the NSE. The stock jumped 2.13% in last one year as compared to a 4.38% slide in NIFTY and a 11.99% spurt in the Nifty Pharma index.
Wockhardt Ltd spurts 8.35%, gains for fifth straight session
Wockhardt Ltd is quoting at Rs 2201.1, up 8.35% on the day as on 12:44 IST on the NSE. The stock is up 50.14% in last one year as compared to a 4.86% jump in NIFTY and a 13.48% jump in the Nifty Pharma.
Leapfrog, IFC and NIIF eye ₹400 crore minority stake in Marengo Asia Healthcare
Marengo will likely use the proceeds to fund its next level growth phase, including inorganic growth plans and expanding its Gurgaon and Faridabad capacity